title: Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.
abstract: OBJECTIVE
  To describe how criteria for amnestic Mild Cognitive Impairment (aMCI) have been operationalised in randomised controlled clinical trials (RCTs).
  
  
  METHODS
  Systematic review.
  
  
  METHODS
  EMBASE, PubMed and PSYCHInfo were searched from their inception to February 2012. Electronic clinical trial registries were also searched (February 2012).
  
  
  METHODS
  RCTs were included where participant selection was made using Petersen et al-defined aMCI. There was no restriction on intervention type or the outcome tested.
  
  
  METHODS
  For each trial, we extracted information on study design, demographics, exclusion criteria and the operationalisation strategy for the five aMCI diagnostic criteria including: (1) memory complaint, (2) normal general cognitive function, (3) memory impairment, (4) no functional impairment and (5) no dementia.
  
  
  RESULTS
  223 articles and 278 registered trials were reviewed, of which 22 met inclusion criteria. Various methods were applied for operationalising aMCI criteria resulting in variability in participant selection. Memory complaint and assessment of general cognitive function were the most consistently measured criteria. There was large heterogeneity in the neuropsychological methods used to determine memory impairment. It was not possible to assess the impact of these differences on case selection accuracy for dementia prediction. Further limitations include selective and unclear reporting of how each of the criteria was measured.
  
  
  CONCLUSIONS
  The results highlight the urgent need for a standardised approach to map aMCI. Lack of uniformity in clinical diagnosis, however, is not exclusively a problem for MCI but also for other clinical states such as dementia including Alzheimer's disease, Lewy Body, frontotemporal or vascular dementia. Defining a uniform approach to MCI classification, or indeed for any classification concept within the field of dementia, should be a priority if further trials are to be undertaken in the older aged population based on these concepts.
authors: Institute of Health and Society, Newcastle University, Newcastle upon Tyne,  UK.
authors: Blossom
authors: B
authors: Christa Maree Stephan
authors: Thais
authors: T
authors: Minett
authors: Emma
authors: E
authors: Pagett
authors: Mario
authors: M
authors: Siervo
authors: Carol
authors: C
authors: Brayne
authors: Ian G
authors: IG
authors: McKeith
references: PLoS Med. 2007 Oct;4(10):1615-9
references: 17973571
references: PLoS One. 2010 Sep 08;5(9):e12244
references: 20838622
references: Neurology. 1993 Feb;43(2):250-60
references: 8094895
references: Lancet Neurol. 2010 Nov;9(11):1118-27
references: 20934914
references: Arch Neurol. 1995 Jun;52(6):612-9
references: 7763211
references: Neurology. 2008 May 27;70(22):2024-35
references: 18322263
references: J Am Geriatr Soc. 2007 Oct;55(10):1534-40
references: 17908056
references: Neuropsychopharmacology. 2005 Jun;30(6):1204-15
references: 15742005
references: J Intern Med. 2004 Sep;256(3):240-6
references: 15324367
references: BMC Geriatr. 2005 Dec 23;5:18
references: 16375760
references: Arch Neurol. 2012 Jan;69(1):29-38
references: 21911655
references: Am J Alzheimers Dis Other Demen. 2005 Sep-Oct;20(5):295-302
references: 16273995
references: N Engl J Med. 2005 Jun 9;352(23):2379-88
references: 15829527
references: J Alzheimers Dis. 2011;25(4):679-94
references: 21483095
references: J Psychiatr Res. 1975 Nov;12(3):189-98
references: 1202204
references: Lancet. 2006 Apr 15;367(9518):1262-70
references: 16631882
references: Psychopharmacol Bull. 1988;24(4):665-70
references: 3249769
references: J Neuropsychiatry Clin Neurosci. 2006 Spring;18(2):178-85
references: 16720794
references: Aging Ment Health. 2005 May;9(3):272-80
references: 16019281
references: Alzheimers Dement. 2010 Sep;6(5):412-9
references: 20813342
references: Aging Ment Health. 2002 Feb;6(1):5-11
references: 11827617
references: PLoS Med. 2009 Jul 21;6(7):e1000097
references: 19621072
references: J Am Geriatr Soc. 2008 Aug;56(8):1424-33
references: 18662209
references: Neurology. 2011 Jan 18;76(3):280-6
references: 21178097
references: J Clin Psychopharmacol. 2007 Feb;27(1):67-70
references: 17224716
references: Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S22-32
references: 9236949
references: Int J Geriatr Psychiatry. 2012 Jun;27(6):592-600
references: 21780182
references: Alzheimers Dement. 2011 May;7(3):270-9
references: 21514249
references: Soc Sci Med. 1996 Dec;43(11):1601-10
references: 8961404
references: Lancet Neurol. 2003 Jan;2(1):15-21
references: 12849297
references: Gerontologist. 1969 Autumn;9(3):179-86
references: 5349366
references: Arch Neurol. 2010 Jan;67(1):71-9
references: 20065132
references: Arch Neurol. 1999 Mar;56(3):303-8
references: 10190820
references: Psychopharmacol Bull. 1988;24(4):641-52
references: 3249766
references: Nat Rev Drug Discov. 2003 Aug;2(8):646-53
references: 12904814
references: J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):730-6
references: 19332424
references: Neurology. 2010 Jan 19;74(3):201-9
references: 20042704
references: Neurobiol Aging. 2007 Oct;28(10):1631-2; discussion 1633-4
references: 16962213
references: Br J Psychiatry. 1982 Jun;140:566-72
references: 7104545
references: Neurobiol Aging. 2011 Oct;32(10):1808-17
references: 20004499
references: Gerontologist. 1970 Spring;10(1):20-30
references: 5420677
references: Int J Geriatr Psychiatry. 2007 Apr;22(4):356-60
references: 17117398
references: J Clin Exp Neuropsychol. 1998 Jun;20(3):310-9
references: 9845158
references: Am J Geriatr Psychiatry. 2011 Nov;19(11):951-60
references: 21422909
references: J Neurol Neurosurg Psychiatry. 2008 May;79(5):500-3
references: 17846114
references: Neurosci Res. 2006 Oct;56(2):159-64
references: 16905216
references: Am J Psychiatry. 1984 Nov;141(11):1356-64
references: 6496779
references: Neurology. 2009 May 5;72(18):1555-61
references: 19176895
references: N Engl J Med. 1997 Dec 4;337(23):1667-74
references: 9385127
references: Am J Psychiatry. 1982 Sep;139(9):1136-9
references: 7114305
references: Neurology. 1984 Jul;34(7):939-44
references: 6610841
references: Acta Psychiatr Scand. 2009 Apr;119(4):252-65
references: 19236314
references: Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1538-44
references: 18573585
references: Lancet Neurol. 2010 Jan;9(1):119-28
references: 20083042
references: Neuropsychol Rehabil. 2010 Jun;20(3):377-405
references: 20029715
references: Int J Geriatr Psychiatry. 2009 Sep;24(9):902-15
references: 19226524
references: Am J Geriatr Psychiatry. 2007 Dec;15(12):1034-45
references: 18056822
references: Arch Neurol. 2001 Dec;58(12):1985-92
references: 11735772
references: Br J Psychiatry. 2011 May;198(5):351-6
references: 21525519
references: Health Policy. 1990 Dec;16(3):199-208
references: 10109801
references: J Gerontol B Psychol Sci Soc Sci. 1998 Jan;53(1):S9-16
references: 9469175
references: Alzheimers Res Ther. 2009 Jul 09;1(1):4
references: 19674437
references: Age Ageing. 1988 Sep;17(5):293-302
references: 2976575
references: Int Psychogeriatr. 2004 Sep;16(3):275-93
references: 15559753
references: Neuropsychol Rehabil. 2008 Jan;18(1):65-88
references: 17943615
references: Alzheimers Dement. 2011 May;7(3):280-92
references: 21514248